Pharmaleads Overview

  • Founded
  • 2000
  • Status
  • Private
  • Employees
  • 10
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $7.27M
Latest Deal Amount
  • Investors
  • 1

Pharmaleads General Information


Developer of non-opiate medicines designed to be used for the treatment of acute and chronic pain. The company's medicines are based on enkephalins, a key element of the physiological pain modulation system, enabling healthcare institutions and patients suffering from severe chronic and acute pain to avail improved pain relief without the side effects associated with other classes of analgesics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 11, rue Watt
  • 75013 Paris
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmaleads Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 01-Jan-2014 $7.27M 000.00 Completed Profitable
1. Later Stage VC 01-Jan-2008 00.000 00.000 Completed Generating Revenue
To view Pharmaleads’s complete valuation and funding history, request access »

Pharmaleads Executive Team (8)

Name Title Board Seat Contact Info
Thierry Bourbié Ph.D Co-Founder, Chief Executive Officer & Chairman
Pierre Maillard Chief Financial Officer
Tanja Ouimet Ph.D Co-Chief Operating Officer & Director of Clinical Development
Jean-Pierre Rogala Co-Chief Operating Officer, Owner and Founding Manager
Hervé Poras Ph.D Chief Scientific Officer & Director of CMC
You’re viewing 5 of 8 executive team members. Get the full list »

Pharmaleads Board Members (7)

Name Representing Role Since
Jean Chalopin Self Board Member 000 0000
Jean-Pierre Kinet MD iXCore Board Member 000 0000
Olivier Heyraud Pharmaleads Board Member 000 0000
Olivier Kreiss Pharmaleads Board Member 000 0000
Pierre Wicker MD Pharmaleads Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Pharmaleads Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmaleads Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
iXCore Venture Capital Minority 000 0000 000000 0
To view Pharmaleads’s complete investors history, request access »